US Stock MarketDetailed Quotes

GNBT GENEREX BIOTECHNOLOGY CORP

Watchlist

0.000600
0.0000000.00%

15min DelayClose Oct 27 16:00 ET

71.07KMarket Cap-1P/E (TTM)

GENEREX BIOTECHNOLOGY CORP Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Apr 30, 2021

(Q2)Jan 31, 2021

(Q1)Oct 31, 2020

(FY)Jul 31, 2020

(Q4)Jul 31, 2020

(Q3)Apr 30, 2020

(Q2)Jan 31, 2020

(Q1)Oct 31, 2019

(FY)Jul 31, 2019

(Q4)Jul 31, 2019

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

166.52%576.69K

64.69%-980.18K

27.57%-1.34M

36.07%-6.12M

58.16%-634.22K

78.79%-866.92K

23.18%-2.78M

-417.07%-1.84M

-317.50%-9.57M

-144.07%-1.52M

Net income from continuing operations

247.29%8.49M

-235.25%-24.41M

-18.00%-10.99M

-211.01%-34.23M

-126.20%-11.88M

48.35%-5.76M

41.23%-7.28M

-152.36%-9.31M

-130.62%-11.01M

-135.44%-5.25M

Operating gains losses

-2,458.47%-15.46M

984.70%15.26M

-279.18%-4.01M

346.17%5.19M

157.52%891.22K

257.09%655.58K

--1.41M

--2.24M

---2.11M

---1.55M

Depreciation and amortization

22.60%280.41K

22.54%281.97K

25.27%278.31K

135.39%1M

360.67%322.82K

32.91%228.73K

-34.73%230.11K

765.65%222.16K

1,693.27%426.44K

-2,076.46%-123.85K

Other non cash items

-81.78%196.9K

-73.86%266.18K

-85.19%305.9K

130.33%4.4M

116.22%234.78K

-48.27%1.08M

-76.84%1.02M

110.57%2.07M

62.83%-14.51M

90.77%-1.45M

Change In working capital

162.53%6.66M

407.39%7.1M

453.46%11.86M

-8.95%10.08M

106.56%4.01M

-45.07%2.54M

-56.88%1.4M

68.21%2.14M

1,353.09%11.08M

740.50%1.94M

-Change in receivables

19.68%117.19K

116.92%14.44K

-573.58%-19.06K

-100.98%-6.27K

61.49%-22.87K

245.82%97.92K

-112.78%-85.34K

458.11%4.02K

1,999.93%637.52K

-77.00%-59.39K

-Change in inventory

873.23%385.77K

175.28%100.74K

124.07%23.63K

-110.05%-113.18K

249.33%168.73K

-105.85%-49.89K

-193.10%-133.83K

-140.53%-98.18K

55,316.86%1.13M

-389,510.34%-112.99K

-Change in payables and accrued expense

-10.98%2.29M

248.28%6.09M

316.11%9.85M

11.56%10.36M

68.57%3.67M

-32.45%2.57M

-23.68%1.75M

135.13%2.37M

964.62%9.29M

994.71%2.18M

-Change in other current assets

-94.23%-117.59K

19.49%-40.72K

90.10%-16.2K

-32.47%17.86K

603.47%292.58K

-165.37%-60.54K

-54.82%-50.57K

-764.89%-163.6K

135.57%26.45K

-188.74%-58.11K

-Change in other current liabilities

23.22%-20.23K

-2,517.61%-2.06M

5,785.80%2.03M

---172.45K

-2,064.19%-101.76K

-32,230.49%-26.35K

-1,804.55%-78.75K

--34.41K

--0

---4.7K

-Change in other working capital

--4M

----

Cash from discontinued investing activities

Operating cash flow

166.52%576.69K

64.69%-980.18K

27.57%-1.34M

36.07%-6.12M

58.16%-634.22K

78.79%-866.92K

23.18%-2.78M

-417.07%-1.84M

-317.50%-9.57M

-144.07%-1.52M

Investing cash flow

Cash flow from continuing investing activities

-98.07%44.69K

-100.03%-165

-95.71%44.85K

27,214.04%2.32M

3,642,100.00%36.42K

Net PPE purchase and sale

----

--0

-267.00%-4.62K

--0

99.20%-165

27.84%-4.45K

132.32%2.76K

3,642,100.00%36.42K

Net intangibles purchase and sale

----

--0

----

--35.6K

--0

Net business purchase and sale

----

--0

-97.84%49.31K

--0

-95.32%49.31K

--2.28M

--0

Cash from discontinued investing activities

Investing cash flow

----

--0

-98.07%44.69K

--0

-100.03%-165

-95.71%44.85K

27,214.04%2.32M

3,642,100.00%36.42K

Financing cash flow

Cash flow from continuing financing activities

-50.73%502.3K

-70.44%740.45K

5.63%2.16M

-10.73%5.81M

-35.63%244.97K

-59.25%1.02M

-16.51%2.51M

226.06%2.04M

1,334.61%6.51M

302.78%380.58K

Net issuance payments of debt

-118.38%-187.34K

-102.82%-67.46K

-102.94%-60K

-12.41%5.7M

-59.80%244.97K

-57.64%1.02M

-19.01%2.4M

281.54%2.04M

5,061.52%6.51M

3,192.93%609.37K

Net common stock issuance

--689.64K

2,321.34%2.66M

--356.71K

--109.77K

--0

--109.77K

--0

Net preferred stock issuance

----

--1.85M

----

--0

----

Proceeds from stock option exercised by employees

---1

--0

--9.14K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

-50.73%502.3K

-70.44%740.45K

5.63%2.16M

-10.73%5.81M

-35.63%244.97K

-59.25%1.02M

-16.51%2.51M

226.06%2.04M

1,334.61%6.51M

302.78%380.58K

Net cash flow

Beginning cash position

121.52%596.03K

54.29%833.57K

-94.82%15.45K

-71.47%298.49K

-70.41%416.64K

-88.67%269.07K

-77.14%540.25K

-71.47%298.49K

-63.66%1.05M

-10.18%1.41M

Current changes in cash

607.27%1.08M

11.69%-239.74K

238.89%820.32K

64.36%-266.11K

64.57%-389.25K

115.67%152.56K

-2,903.67%-271.48K

-81.60%242.06K

59.60%-746.67K

-108.68%-1.1M

Effect of exchange rate changes

----

-648.98%-2.2K

-1,302.99%-16.92K

-13.17%-11.94K

----

-118.08%-294

-107.90%-1.21K

-292.03%-10.55K

End cash Position

302.03%1.68M

121.52%596.03K

54.29%833.57K

-94.82%15.45K

-70.41%416.64K

-88.67%269.07K

-77.14%540.25K

-71.47%298.49K

Free cash flow

166.52%576.69K

64.70%-980.18K

27.74%-1.34M

38.06%-6.13M

58.28%-634.22K

80.06%-866.92K

24.16%-2.78M

-409.51%-1.85M

-329.70%-9.89M

-144.76%-1.52M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Apr 30, 2021	(Q2)Jan 31, 2021	(Q1)Oct 31, 2020	(FY)Jul 31, 2020	(Q4)Jul 31, 2020	(Q3)Apr 30, 2020	(Q2)Jan 31, 2020	(Q1)Oct 31, 2019	(FY)Jul 31, 2019	(Q4)Jul 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	166.52%576.69K	64.69%-980.18K	27.57%-1.34M	36.07%-6.12M	58.16%-634.22K	78.79%-866.92K	23.18%-2.78M	-417.07%-1.84M	-317.50%-9.57M	-144.07%-1.52M
Net income from continuing operations	247.29%8.49M	-235.25%-24.41M	-18.00%-10.99M	-211.01%-34.23M	-126.20%-11.88M	48.35%-5.76M	41.23%-7.28M	-152.36%-9.31M	-130.62%-11.01M	-135.44%-5.25M
Operating gains losses	-2,458.47%-15.46M	984.70%15.26M	-279.18%-4.01M	346.17%5.19M	157.52%891.22K	257.09%655.58K	--1.41M	--2.24M	---2.11M	---1.55M
Depreciation and amortization	22.60%280.41K	22.54%281.97K	25.27%278.31K	135.39%1M	360.67%322.82K	32.91%228.73K	-34.73%230.11K	765.65%222.16K	1,693.27%426.44K	-2,076.46%-123.85K
Other non cash items	-81.78%196.9K	-73.86%266.18K	-85.19%305.9K	130.33%4.4M	116.22%234.78K	-48.27%1.08M	-76.84%1.02M	110.57%2.07M	62.83%-14.51M	90.77%-1.45M
Change In working capital	162.53%6.66M	407.39%7.1M	453.46%11.86M	-8.95%10.08M	106.56%4.01M	-45.07%2.54M	-56.88%1.4M	68.21%2.14M	1,353.09%11.08M	740.50%1.94M
-Change in receivables	19.68%117.19K	116.92%14.44K	-573.58%-19.06K	-100.98%-6.27K	61.49%-22.87K	245.82%97.92K	-112.78%-85.34K	458.11%4.02K	1,999.93%637.52K	-77.00%-59.39K
-Change in inventory	873.23%385.77K	175.28%100.74K	124.07%23.63K	-110.05%-113.18K	249.33%168.73K	-105.85%-49.89K	-193.10%-133.83K	-140.53%-98.18K	55,316.86%1.13M	-389,510.34%-112.99K
-Change in payables and accrued expense	-10.98%2.29M	248.28%6.09M	316.11%9.85M	11.56%10.36M	68.57%3.67M	-32.45%2.57M	-23.68%1.75M	135.13%2.37M	964.62%9.29M	994.71%2.18M
-Change in other current assets	-94.23%-117.59K	19.49%-40.72K	90.10%-16.2K	-32.47%17.86K	603.47%292.58K	-165.37%-60.54K	-54.82%-50.57K	-764.89%-163.6K	135.57%26.45K	-188.74%-58.11K
-Change in other current liabilities	23.22%-20.23K	-2,517.61%-2.06M	5,785.80%2.03M	---172.45K	-2,064.19%-101.76K	-32,230.49%-26.35K	-1,804.55%-78.75K	--34.41K	--0	---4.7K
-Change in other working capital	--4M	----	----	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	166.52%576.69K	64.69%-980.18K	27.57%-1.34M	36.07%-6.12M	58.16%-634.22K	78.79%-866.92K	23.18%-2.78M	-417.07%-1.84M	-317.50%-9.57M	-144.07%-1.52M
Investing cash flow
Cash flow from continuing investing activities			0	-98.07%44.69K	0	0	-100.03%-165	-95.71%44.85K	27,214.04%2.32M	3,642,100.00%36.42K
Net PPE purchase and sale	----	----	--0	-267.00%-4.62K	--0	--0	99.20%-165	27.84%-4.45K	132.32%2.76K	3,642,100.00%36.42K
Net intangibles purchase and sale	----	----	----	--0	----	----	----	----	--35.6K	--0
Net business purchase and sale	----	----	--0	-97.84%49.31K	--0	--0	--0	-95.32%49.31K	--2.28M	--0
Cash from discontinued investing activities
Investing cash flow	----	----	--0	-98.07%44.69K	--0	--0	-100.03%-165	-95.71%44.85K	27,214.04%2.32M	3,642,100.00%36.42K
Financing cash flow
Cash flow from continuing financing activities	-50.73%502.3K	-70.44%740.45K	5.63%2.16M	-10.73%5.81M	-35.63%244.97K	-59.25%1.02M	-16.51%2.51M	226.06%2.04M	1,334.61%6.51M	302.78%380.58K
Net issuance payments of debt	-118.38%-187.34K	-102.82%-67.46K	-102.94%-60K	-12.41%5.7M	-59.80%244.97K	-57.64%1.02M	-19.01%2.4M	281.54%2.04M	5,061.52%6.51M	3,192.93%609.37K
Net common stock issuance	--689.64K	2,321.34%2.66M	--356.71K	--109.77K	--0	--0	--109.77K	--0	--0	--0
Net preferred stock issuance	----	----	--1.85M	----	----	----	----	--0	----	----
Proceeds from stock option exercised by employees	---1	--0	--9.14K	----	----	--0	--0	--0	----	----
Cash from discontinued financing activities
Financing cash flow	-50.73%502.3K	-70.44%740.45K	5.63%2.16M	-10.73%5.81M	-35.63%244.97K	-59.25%1.02M	-16.51%2.51M	226.06%2.04M	1,334.61%6.51M	302.78%380.58K
Net cash flow
Beginning cash position	121.52%596.03K	54.29%833.57K	-94.82%15.45K	-71.47%298.49K	-70.41%416.64K	-88.67%269.07K	-77.14%540.25K	-71.47%298.49K	-63.66%1.05M	-10.18%1.41M
Current changes in cash	607.27%1.08M	11.69%-239.74K	238.89%820.32K	64.36%-266.11K	64.57%-389.25K	115.67%152.56K	-2,903.67%-271.48K	-81.60%242.06K	59.60%-746.67K	-108.68%-1.1M
Effect of exchange rate changes	----	----	-648.98%-2.2K	-1,302.99%-16.92K	-13.17%-11.94K	----	----	-118.08%-294	-107.90%-1.21K	-292.03%-10.55K
End cash Position	302.03%1.68M	121.52%596.03K	54.29%833.57K	-94.82%15.45K	-94.82%15.45K	-70.41%416.64K	-88.67%269.07K	-77.14%540.25K	-71.47%298.49K	-71.47%298.49K
Free cash flow	166.52%576.69K	64.70%-980.18K	27.74%-1.34M	38.06%-6.13M	58.28%-634.22K	80.06%-866.92K	24.16%-2.78M	-409.51%-1.85M	-329.70%-9.89M	-144.76%-1.52M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall